Form 144 AMGEN INC For: 20 February
#Form 144 #Amgen #SEC filing #stock market #Fed minutes #Nvidia #OpenAI #gold prices
📌 Key Takeaways
- Amgen filed Form 144 indicating insider intent to sell restricted securities
- US stocks fell after hawkish Fed minutes and weak Walmart guidance
- Nvidia and OpenAI reportedly near $30 billion investment deal
- Gold prices rose amid US-Iran tensions despite weekly losses
📖 Full Retelling
🏷️ Themes
SEC Filings, Market Performance, Investment News
📚 Related People & Topics
Amgen
American multinational biopharmaceutical company
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue.
OpenAI
Artificial intelligence research organization
# OpenAI **OpenAI** is an American artificial intelligence (AI) research organization headquartered in San Francisco, California. The organization operates under a unique hybrid structure, comprising the non-profit **OpenAI, Inc.** and its controlled for-profit subsidiary, **OpenAI Global, LLC** (a...
SEC filing
Type of financial statements in the United States
# SEC Filing An **SEC filing** is a formal financial statement or regulatory document submitted to the **U.S. Securities and Exchange Commission (SEC)**. These filings are mandatory requirements designed to ensure transparency, providing a standardized method for disclosing material information to ...
Nvidia
American multinational technology company
Nvidia Corporation ( en-VID-ee-ə) is an American technology company headquartered in Santa Clara, California. Founded in 1993 by Jensen Huang, Chris Malachowsky, and Curtis Priem, it develops graphics processing units (GPUs), systems on chips (SoCs), and application programming interfaces (APIs) for...
Entity Intersection Graph
No entity connections available yet for this article.
Deep Analysis
Why It Matters
Form 144 filings signal that insiders are selling shares, which can indicate a lack of confidence or a need for liquidity. For a large biotech company like Amgen, such sales may affect investor perception and the stock's volatility.
Context & Background
- Amgen is a leading biopharmaceutical company.
- Form 144 allows insiders to disclose planned sales.
- Insider selling can influence market sentiment.
- The filing was made on 20 February 2026.
- The stock closed at -1.11% on that day.
What Happens Next
The sale will be executed over a 30‑day period, subject to regulatory approval. Investors should monitor the filing for any changes in insider ownership and potential price impact.
Frequently Asked Questions
A Form 144 is a notice filed with the SEC when an insider intends to sell restricted or control shares, providing transparency to the market.
Insiders may need liquidity, diversify holdings, or plan for future investments; it does not necessarily reflect on the company's fundamentals.
Short‑term price movements can occur, but the impact depends on the sale size relative to the company's market cap and overall market conditions.